Abstract Details

Title Assessment of Neuronal Pathology in the Cerebral Grey Matter of Patients with MS: Added Value of PET with [11C]-Flumazenil

Topic MS and Related Diseases

Presentation(s) (-)

Poster/Presentation
Number 123

Objective

Background

Design/Methods

Results

Conclusions

Authors/Disclosures
Michel Bottlaender (Centre Hospitalier Frederic Joliot)	Michel Bottlaender has nothing to disclose.
	No disclosure on file
	No disclosure on file
	No disclosure on file
	No disclosure on file
Rana Assouad, MD	No disclosure on file
	No disclosure on file
Catherine Lubetzki (Hopital De La Salpetriere)	Catherine Lubetzki has received personal compensation in the range of $500-$4,999 for serving as a Consultant for ROCHE. Catherine Lubetzki has received personal compensation in the range of $500-$4,999 for serving as a Consultant for MERCK SERONO. Catherine Lubetzki has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for REWIND.
Leorah Freeman, MD (Ch Pitie Salpetriere)	No disclosure on file

��ɫ��